A role for caveolin-1 in desmoglein binding and desmosome dynamics

D. Brennan, S. Peltonen, A. Dowling, W. Medhat, K. J. Green, James K Wahl, F. Del Galdo, M. G. Mahoney

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Desmoglein-2 (Dsg2) is a desmosomal cadherin that is aberrantly expressed in human skin carcinomas. In addition to its well-known role in mediating intercellular desmosomal adhesion, Dsg2 regulates mitogenic signaling that may promote cancer development and progression. However, the mechanisms by which Dsg2 activates these signaling pathways and the relative contribution of its signaling and adhesion functions in tumor progression are poorly understood. In this study we show that Dsg2 associates with caveolin-1 (Cav-1), the major protein of specialized membrane microdomains called caveolae, which functions in both membrane protein turnover and intracellular signaling. Sequence analysis revealed that Dsg2 contains a putative Cav-1-binding motif. A permeable competing peptide resembling the Cav-1 scaffolding domain bound to Dsg2, disrupted normal Dsg2 staining and interfered with the integrity of epithelial sheets in vitro. Additionally, we observed that Dsg2 is proteolytically processed; resulting in a 95-kDa ectodomain shed product and a 65-kDa membrane-spanning fragment, the latter of which localizes to lipid rafts along with full-length Dsg2. Disruption of lipid rafts shifted Dsg2 to the non-raft fractions, leading to the accumulation of these proteins. Interestingly, Dsg2 proteolytic products are elevated in vivo in skin tumors from transgenic mice overexpressing Dsg2. Collectively, these data are consistent with the possibility that accumulation of truncated Dsg2 protein interferes with desmosome assembly and/or maintenance to disrupt cell-cell adhesion. Furthermore, the association of Dsg2 with Cav-1 may provide a mechanism for regulating mitogenic signaling and modulating the cell-surface presentation of an important adhesion molecule, both of which could contribute to malignant transformation and tumor progression.

Original languageEnglish (US)
Pages (from-to)1636-1648
Number of pages13
JournalOncogene
Volume31
Issue number13
DOIs
StatePublished - Mar 29 2012

Fingerprint

Desmoglein 2
Desmogleins
Caveolin 1
Desmosomes
Neoplasms
Desmosomal Cadherins
Membrane Microdomains
Lipids
Caveolae
Skin

Keywords

  • carcinogenesis
  • caveolae
  • caveolin
  • desmoglein
  • keratinocyte

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Brennan, D., Peltonen, S., Dowling, A., Medhat, W., Green, K. J., Wahl, J. K., ... Mahoney, M. G. (2012). A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene, 31(13), 1636-1648. https://doi.org/10.1038/onc.2011.346

A role for caveolin-1 in desmoglein binding and desmosome dynamics. / Brennan, D.; Peltonen, S.; Dowling, A.; Medhat, W.; Green, K. J.; Wahl, James K; Del Galdo, F.; Mahoney, M. G.

In: Oncogene, Vol. 31, No. 13, 29.03.2012, p. 1636-1648.

Research output: Contribution to journalArticle

Brennan, D, Peltonen, S, Dowling, A, Medhat, W, Green, KJ, Wahl, JK, Del Galdo, F & Mahoney, MG 2012, 'A role for caveolin-1 in desmoglein binding and desmosome dynamics', Oncogene, vol. 31, no. 13, pp. 1636-1648. https://doi.org/10.1038/onc.2011.346
Brennan D, Peltonen S, Dowling A, Medhat W, Green KJ, Wahl JK et al. A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene. 2012 Mar 29;31(13):1636-1648. https://doi.org/10.1038/onc.2011.346
Brennan, D. ; Peltonen, S. ; Dowling, A. ; Medhat, W. ; Green, K. J. ; Wahl, James K ; Del Galdo, F. ; Mahoney, M. G. / A role for caveolin-1 in desmoglein binding and desmosome dynamics. In: Oncogene. 2012 ; Vol. 31, No. 13. pp. 1636-1648.
@article{076edf436e564db690394c15954391ee,
title = "A role for caveolin-1 in desmoglein binding and desmosome dynamics",
abstract = "Desmoglein-2 (Dsg2) is a desmosomal cadherin that is aberrantly expressed in human skin carcinomas. In addition to its well-known role in mediating intercellular desmosomal adhesion, Dsg2 regulates mitogenic signaling that may promote cancer development and progression. However, the mechanisms by which Dsg2 activates these signaling pathways and the relative contribution of its signaling and adhesion functions in tumor progression are poorly understood. In this study we show that Dsg2 associates with caveolin-1 (Cav-1), the major protein of specialized membrane microdomains called caveolae, which functions in both membrane protein turnover and intracellular signaling. Sequence analysis revealed that Dsg2 contains a putative Cav-1-binding motif. A permeable competing peptide resembling the Cav-1 scaffolding domain bound to Dsg2, disrupted normal Dsg2 staining and interfered with the integrity of epithelial sheets in vitro. Additionally, we observed that Dsg2 is proteolytically processed; resulting in a 95-kDa ectodomain shed product and a 65-kDa membrane-spanning fragment, the latter of which localizes to lipid rafts along with full-length Dsg2. Disruption of lipid rafts shifted Dsg2 to the non-raft fractions, leading to the accumulation of these proteins. Interestingly, Dsg2 proteolytic products are elevated in vivo in skin tumors from transgenic mice overexpressing Dsg2. Collectively, these data are consistent with the possibility that accumulation of truncated Dsg2 protein interferes with desmosome assembly and/or maintenance to disrupt cell-cell adhesion. Furthermore, the association of Dsg2 with Cav-1 may provide a mechanism for regulating mitogenic signaling and modulating the cell-surface presentation of an important adhesion molecule, both of which could contribute to malignant transformation and tumor progression.",
keywords = "carcinogenesis, caveolae, caveolin, desmoglein, keratinocyte",
author = "D. Brennan and S. Peltonen and A. Dowling and W. Medhat and Green, {K. J.} and Wahl, {James K} and {Del Galdo}, F. and Mahoney, {M. G.}",
year = "2012",
month = "3",
day = "29",
doi = "10.1038/onc.2011.346",
language = "English (US)",
volume = "31",
pages = "1636--1648",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "13",

}

TY - JOUR

T1 - A role for caveolin-1 in desmoglein binding and desmosome dynamics

AU - Brennan, D.

AU - Peltonen, S.

AU - Dowling, A.

AU - Medhat, W.

AU - Green, K. J.

AU - Wahl, James K

AU - Del Galdo, F.

AU - Mahoney, M. G.

PY - 2012/3/29

Y1 - 2012/3/29

N2 - Desmoglein-2 (Dsg2) is a desmosomal cadherin that is aberrantly expressed in human skin carcinomas. In addition to its well-known role in mediating intercellular desmosomal adhesion, Dsg2 regulates mitogenic signaling that may promote cancer development and progression. However, the mechanisms by which Dsg2 activates these signaling pathways and the relative contribution of its signaling and adhesion functions in tumor progression are poorly understood. In this study we show that Dsg2 associates with caveolin-1 (Cav-1), the major protein of specialized membrane microdomains called caveolae, which functions in both membrane protein turnover and intracellular signaling. Sequence analysis revealed that Dsg2 contains a putative Cav-1-binding motif. A permeable competing peptide resembling the Cav-1 scaffolding domain bound to Dsg2, disrupted normal Dsg2 staining and interfered with the integrity of epithelial sheets in vitro. Additionally, we observed that Dsg2 is proteolytically processed; resulting in a 95-kDa ectodomain shed product and a 65-kDa membrane-spanning fragment, the latter of which localizes to lipid rafts along with full-length Dsg2. Disruption of lipid rafts shifted Dsg2 to the non-raft fractions, leading to the accumulation of these proteins. Interestingly, Dsg2 proteolytic products are elevated in vivo in skin tumors from transgenic mice overexpressing Dsg2. Collectively, these data are consistent with the possibility that accumulation of truncated Dsg2 protein interferes with desmosome assembly and/or maintenance to disrupt cell-cell adhesion. Furthermore, the association of Dsg2 with Cav-1 may provide a mechanism for regulating mitogenic signaling and modulating the cell-surface presentation of an important adhesion molecule, both of which could contribute to malignant transformation and tumor progression.

AB - Desmoglein-2 (Dsg2) is a desmosomal cadherin that is aberrantly expressed in human skin carcinomas. In addition to its well-known role in mediating intercellular desmosomal adhesion, Dsg2 regulates mitogenic signaling that may promote cancer development and progression. However, the mechanisms by which Dsg2 activates these signaling pathways and the relative contribution of its signaling and adhesion functions in tumor progression are poorly understood. In this study we show that Dsg2 associates with caveolin-1 (Cav-1), the major protein of specialized membrane microdomains called caveolae, which functions in both membrane protein turnover and intracellular signaling. Sequence analysis revealed that Dsg2 contains a putative Cav-1-binding motif. A permeable competing peptide resembling the Cav-1 scaffolding domain bound to Dsg2, disrupted normal Dsg2 staining and interfered with the integrity of epithelial sheets in vitro. Additionally, we observed that Dsg2 is proteolytically processed; resulting in a 95-kDa ectodomain shed product and a 65-kDa membrane-spanning fragment, the latter of which localizes to lipid rafts along with full-length Dsg2. Disruption of lipid rafts shifted Dsg2 to the non-raft fractions, leading to the accumulation of these proteins. Interestingly, Dsg2 proteolytic products are elevated in vivo in skin tumors from transgenic mice overexpressing Dsg2. Collectively, these data are consistent with the possibility that accumulation of truncated Dsg2 protein interferes with desmosome assembly and/or maintenance to disrupt cell-cell adhesion. Furthermore, the association of Dsg2 with Cav-1 may provide a mechanism for regulating mitogenic signaling and modulating the cell-surface presentation of an important adhesion molecule, both of which could contribute to malignant transformation and tumor progression.

KW - carcinogenesis

KW - caveolae

KW - caveolin

KW - desmoglein

KW - keratinocyte

UR - http://www.scopus.com/inward/record.url?scp=84859424177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859424177&partnerID=8YFLogxK

U2 - 10.1038/onc.2011.346

DO - 10.1038/onc.2011.346

M3 - Article

C2 - 21841821

AN - SCOPUS:84859424177

VL - 31

SP - 1636

EP - 1648

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 13

ER -